	Cardiac-specific mortality prediction in adolescents and young adults with classical hodgkin lymphoma: a nomogram development and validation. Sci Rep Yan R, Niu J, Zhang W, Zhang Y, Li J, Li S. PMID: 42103852 [PubMed - as supplied by publisher]
	Renal presentation of diffuse large B-cell lymphoma emerging after pre-existing IgG4-related disease and monoclonal gammopathy of undetermined significance. BMJ Case Rep Jlasi A, Gomez A, Deng X. PMID: 42103345 [PubMed - indexed for MEDLINE]
	Evolving Paradigms in the Treatment of Philadelphia Chromosome-Positive ALL. Am Soc Clin Oncol Educ Book Short NJ, Ribera JM, Abou Dalle I, Goulart H, Ribera J, Mohty M, Torrent A, Bazarbachi A. PMID: 42102341 [PubMed - indexed for MEDLINE]
	Revisiting KIR Restriction and CD94 Expression in Diagnostic Criteria for NK-Large Granular Lymphocytic Leukemia. Blood Adv Seheult JN, Otteson GE, Jevremovic D, Morice WW, Timm MM, Hsi ED, Olteanu H, Horna P, Shi M. PMID: 42102292 [PubMed - as supplied by publisher]
	Optimal minimal residual disease threshold in pediatric acute myeloid leukemia: A retrospective cohort study based on the TARGET database. PLoS Med Liao XY, Zheng H, Fang JP, Zhou DH, Qiu KY. PMID: 42102025 [PubMed - indexed for MEDLINE]
	Economic Evaluation of Axicabtagene Ciloleucel as a Second-Line Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in South Korea: A Cost-Utility Analysis Based on the ZUMA-7 Trial. Clin Drug Investig Lee J, Kim M, Jang M, Jo S, Lee S, Suh HS. PMID: 42101810 [PubMed - as supplied by publisher]
	Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group. Hemasphere Sesques P, Manson G, Cartron G, Gros FX, Morschhauser F, Castilla-Llorente C, Brisou G, Bories P, Thieblemont C, Drieu La Rochelle L, Tessoulin B, André A, Rossi C, Paillassa J, Guidez S, Capes A, Herbreteau L, Choquet S, Bay JO, Chauchet A, Lebras L, Claves F, Abraham J, Malfuson JV, Rubio MT, Decroocq J, Fornecker LM, Damaj G, Fouillet L, Joris M, Loschi M, Hermine O, Hafirassou H, Zele EV, Dupont V, Gouill SL, Houot R, Camus V. PMID: 42099680 [PubMed]
	Extracavitary Primary Effusion Lymphoma: Diagnostic Challenges and Differential Diagnosis in a Resource-Constrained South African Setting. Int J Surg Pathol Mwazha A, Nhlonzi BG. PMID: 42099060 [PubMed - as supplied by publisher]
	Aquaporin-9 expression as an independent adverse prognostic marker in diffuse large B-cell lymphoma: an immunohistochemical tissue microarray study. J Mol Histol Farrag MS, Hemada MS, Elashwah S, William MI, El-Ashwah S, Ibrahim EM. PMID: 42098514 [PubMed - indexed for MEDLINE]
	Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group. Bone Marrow Transplant Colmenares R, Barragán E, Rodríguez-Veiga R, Torres-Miñana L, Sánchez-García J, Tormo M, Bernal T, Martínez-Sánchez P, Rodríguez-Arbolí E, Gil C, Soria-Saldise E, Serrano J, Colorado M, García-Fortes M, Bilbao C, López-Lorenzo JL, Larráyoz MJ, Pérez-Santaolalla E, Lavilla-Rubira E, Algarra L, García-Garay MC, Chillón C, Torres-Ochando M, Couto C, García-Boyero R, Almela Á, Noriega V, Callejas M, Barrios M, Casado S, Balerdi A, Cabello A, Labrador J, Mateos MC, Amigo ML, Pérez-Encinas M, García-Pérez MJ, Costilla L, Bergua J, Carreño-Tarragona G, Martínez-López J, Ayala R, Montesinos P, PETHEMA Group. PMID: 42098381 [PubMed - as supplied by publisher]
	A phase II study of daratumumab and ibrutinib for relapsed/refractory chronic lymphocytic leukemia. Blood Cancer J Parrondo RD, Ailawadhi S, Knopf BR, Zimmerman A, Kasik CJ, Chapin D, Heslop K, Roy V, Paulus A, Chanan-Khan AA. PMID: 42098065 [PubMed - in process]
	Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol. BMJ Open Reynolds GK, Anderson MA, Thursky K, Teh BW, Slavin MA. PMID: 42097661 [PubMed - indexed for MEDLINE]
	Diagnostic Performance and Complementary Value of Molecular, Cytokine, and Clonality Biomarkers for Primary Vitreoretinal Lymphoma: A Systematic Review and Meta-analysis. Ophthalmology Lou Y, Ma C, Zhang X, Zhang M, Chai H, Zhao Y, Liu X. PMID: 42097331 [PubMed - as supplied by publisher]
	Modern Management of Mantle Cell Lymphoma. Am Soc Clin Oncol Educ Book Tix T, Kumar A, Eyre TA, Dreyling M. PMID: 42096665 [PubMed - indexed for MEDLINE]
	Revealing the promising therapeutic targets and prognostic markers of primary mediastinal large B-cell lymphoma. Discov Oncol Liu Y, Li S, Zhang C, Zhang J, Li Y. PMID: 42096000 [PubMed - as supplied by publisher]
	Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial). Haematologica Kikuchi S, Negoro E, Horaguchi R, Fujihira T, Nabe Y, Minemura T, Ono K, Kamihara Y, Wada A, Dang NH, Masaki Y, Miyamoto T, Yamauchi T, Sato T. PMID: 42095246 [PubMed - as supplied by publisher]
	Factors associated with executive function in children with lymphoma undergoing chemotherapy: A cross-sectional study based on the theory of unpleasant symptoms. Asia Pac J Oncol Nurs Guo X, He M, Sun J, Shen N, Zhang Y. PMID: 42094776 [PubMed]
	Feasibility of Non-Sedated Multispectral Neuroimaging in Newly Diagnosed Children with Leukemia. medRxiv Tran MK, Appell L, Chung S, Sanders M, Jones A, Fenwick M, Oest E, Ou X, Farrar J, Brown AW, Koscik TR, van der Plas E. PMID: 42094139 [PubMed]
	PET/CT radiomics-biomarker diagnostic model for identifying lymphoma in fever of unknown origin. Front Immunol Jing F, Zhang X, Hua R, Zhang J, Li K, Cai X, Tian C, Wei Q, Bian Y. PMID: 42094006 [PubMed - indexed for MEDLINE]
	Toward a chemotherapy and allo-HSCT free future: the evolution of treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia. Front Immunol Yang Q. PMID: 42094005 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 167577

Page 1 of 8379



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy